It has also been reported that high ALOX5 expression is significantly associated with a poor prognosis in colorectal cancer, gastric cancer, clear cell renal cell carcinoma, papillary thyroid carcinoma, and other tumors [40–43]. This evidence concerns the gene ALOX5 and differentiated thyroid carcinoma.